http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2010128019-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2008-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2012-01-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2010128019-A |
| titleOfInvention | ORAL DISPERSABLE TABLET |
| abstract | 1. Not effervescent tablet for oral administration containing an effective amount of at least one active agent, at least 50% wt./wt. water-insoluble particles, a surfactant and a disintegrant such that said tablet is orally disintegrable or dispersible. ! 2. The tablet according to claim 1, where the specified tablet is split in the oral cavity in no more than 60 seconds. ! 3. The tablet according to claim 1, where the specified water-insoluble carrier is selected from the group consisting of cellulose, microcrystalline cellulose or silicified microcrystalline cellulose, or mixtures thereof. ! 4. The tablet according to claim 3, where the specified silicified microcrystalline cellulose is contained in an amount of from 20% to 90%. ! 5. The tablet according to claim 3, where the specified silicified microcrystalline cellulose has an average particle size of from 20 to 300 microns. ! 6. The tablet according to claim 1, wherein said disintegrant is selected from the group consisting of low substituted hydroxypropyl cellulose, carboxymethyl cellulose, croscarmellose sodium, crospovidone (cross-linked polyvinylpyrrolidone), sodium starch glycolate, starch, and a combination thereof. ! 7. The tablet of claim 1, wherein said surfactant is selected from the group consisting of sodium dodecyl sulfate, fatty acid esters of polyoxyethylene sorbitan (Tweens), polyoxyethylene stearates, fatty acid esters of sorbitan (Spans). ! 8. The tablet according to claim 1, wherein said active agent is selected from the group consisting of pharmaceutically active agents, nutrients, nutraceuticals and cosmetics. !9. A tablet according to claims 1 to 8, wherein said pharmaceutically active agent is selected from |
| priorityDate | 2007-12-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 109.